gracecastuc-043_ca-101_will costs of care limit our ability to deliver cancer treatments?
Published 11 years ago • 26 plays • Length 2:29Download video MP4
Download video MP3
Similar videos
-
1:59:57
grace - global resource for advancing cancer education live stream
-
12:20
cost of & access to molecularly targeted therapies as barriers to optimal care
-
5:09
gracecastuc-013_lung_what should we do for a "mixed response" to lung cancer treatment?
-
3:34
gracecastuc-014_ca-101_thanks so much for your support in 2012: here's to a great 2013!
-
3:58
gracecastuc-009_ca-101_do we need to do repeat biopsies with disease progression?
-
3:58
cancer genetics 101: insurance for ngs & closing points-patient education ambassadors 2023-24
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
25:07
gracecast-101_lung-cancer_mm in lc pt6: dr. goss on incorporating markers across a hc system
-
6:19
tumor treating fields: an overview- mesothelioma and glioblastoma, 2024
-
1:12
gracecastuc-053_lung_will gains in targeted therapies be generalizable to a wider range of lc?
-
4:20
gracecastuc-002 - how should we treat locally advanced non-small cell lung cancer?
-
1:26
gracecastuc-047_lung_potential value of treatment break as alt. to maint. therapy in advanced nsclc
-
41:20
gracecast-082_lung-cancer_challenges and special considerations in treating elderly patients
-
7:37
gracecastuc-016_lung_a high profile failure for stimuvax: implications for future trials
-
3:59
clinical trials 101: what is a clinical trial? - program: patient education ambassadors 2023-24
-
2:00
gracecastuc-001 - intro to casual video gracecasts, the uncut series
-
5:11
gracecastuc-015_lung_what is the biology of a mixed response in lung cancer?
-
3:29
palliative care during cancer treatment - patient education ambassadors 2023-24
-
5:42
gracecastuc-006 - which patients with advanced lung cancer should potentially receive local therapy?